![](http://web.archive.org./web/20170308155151im_/https://static01.nyt.com/images/2017/03/08/science/08TAXCREDIT4/08TAXCREDIT4-videoLarge.jpg)
Millions Risk Losing Health Insurance in Republican Plan, Analysts Say
Americans in their 50s and 60s would be especially likely to find coverage unaffordable in a system providing tax credits of $2,000 to $4,000 per year based on age.
Advertisement
Americans in their 50s and 60s would be especially likely to find coverage unaffordable in a system providing tax credits of $2,000 to $4,000 per year based on age.
By ABBY GOODNOUGH and REED ABELSON
Maps comparing tax credits under the Affordable Care act and those in the plan House Republicans recently released across groups of incomes and ages.
By KEVIN QUEALY and MARGOT SANGER-KATZ
In comparison with the pace of work on the Affordable Care Act in 2009, the timetable for the Republicans’ health care bill is lightning fast.
By ROBERT PEAR
Before the bill has even reached House committees, conservative senators and groups have come out against the plan to replace the Affordable Care Act.
By JENNIFER STEINHAUER
For families of people near death, Trish Rogers provides a unique memorial — a cast made from the patient’s hand, often joined with the hand of a loved one.
By DENISE GRADY
The Frugal Family heads to Thailand and learns why a surprising number of people travel abroad to get fillings and crowns, whitening and implants.
By FREDA MOON
Ping-Pong, or table tennis as it is officially known, is one of the fastest racket sports, requiring muscular and cardiorespiratory endurance.
By WENDY LYONS SUNSHINE
Loss of sexual intimacy often goes unmentioned even by close friends.
By JANE E. BRODY
Despite uncertainty about the Affordable Care Act’s future, Utah had one of the biggest increases of any state in residents who signed up for its coverage this year.
By ABBY GOODNOUGH
Most major cancer centers post the trials in which they participate on their websites. But other sites show more options.
By DENISE GRADY
As immunotherapy research takes off, the patients getting the treatment have been overwhelmingly white. Researchers know this and say they are trying to correct it.
By DENISE GRADY
Public funding is backing a new immunotherapy treatment, but the bulk of any profits will go to a private company. So are taxpayers getting a good deal?
By MATT RICHTEL and ANDREW POLLACK
The science reporter Denise Grady writes about the connection between two immunotherapy success stories.
By DENISE GRADY
The recovery of a woman with advanced colon cancer, after treatment with cells from her own immune system, may help doctors develop new treatments for other patients.
By DENISE GRADY